|
DNA-debate |
DNA-debate |
February 1, 2018 |
November 1, 2020 |
Kankercentrum |
|
|
The Belgian Survey on Drugs |
DrugVibes |
April 1, 2019 |
|
Health information |
illegal drugs, illegal medicine, lifestyle risk factors, cannabis, weed, marijuana, hashish, powder cocaine, coke, crack cocaine, base, ecstasy, XTC, MDMA, amphetamines, speed, heroin, methamphetamines, crystal meth, GHB, GBL, liquid ecstasy, ketamine, LSD, hallucinogens, magic mushrooms, DMT, ayahuasca, alcohol, laughing gas, new psychoactive substances, opioid medication, tranquilizers, stimulant medication |
|
Characterization of e-cigarette emissions |
E-CIGAER |
November 16, 2022 |
November 15, 2024 |
Medicines and health products |
|
|
Characterisation and risk evaluation of electronic cigarettes and related products |
e-SMOKE |
November 3, 2015 |
November 2, 2019 |
Medicines and health products, Risk and health impact assessment |
e-cigarettes, quality control, nicotine replacement therapy, genotoxicity, mutagenicity |
|
European Antimicrobial Resistance Surveillance: Belgium |
EARS-BE |
January 1, 2000 |
|
Healthcare-associated infections and antimicrobial resistance |
klinisch laboratorium, ziekenhuis, zorginfectie, ECDC, WHO |
|
Mapping the Environmental Burden of Disease in Flanders |
EBoD-FL |
January 1, 2022 |
December 31, 2026 |
Risk and health impact assessment, Health information |
air pollution, comparative risk assessment, Environmental burden of disease, extreme temperatures, noise |
|
EU Joint Action on strengthening eHealth including telemedicine and remote monitoring for health care systems for cancer prevention and care |
eCAN JA |
September 15, 2022 |
September 15, 2024 |
Cancer centre |
networks, expertise, cancer |
|
Point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals |
ECDC-PPS |
January 1, 2011 |
|
Healthcare-associated infections and antimicrobial resistance |
nosocomial infection, healthcare-associated infection, antibiotics, acute hospitals |
|
Establishing of Cancer Mission Hubs: Networks and Synergies |
ECHos |
May 1, 2023 |
May 1, 2026 |
Cancer centre |
cancer, prevention, early detection & screening, rehabilitation, quality of life, paedeatric cancers, AI, Research |
|
Development of biomarkers for endocrine disruptors |
EDC BIRTHCOHORT |
April 1, 2015 |
December 31, 2019 |
Risk and health impact assessment |
endocrine disruptor, exposure, placenta, birth cohort (mother-child cohort) |
|
Whole genome sequence (WGS) analysis of micro-organisms intentionally added to food and feed |
EFSA-FEED 2021 |
April 11, 2022 |
June 11, 2023 |
Transversal activities in applied genomics |
food safety, microbial fermentation products, genetically modified microorganisms, whole genome sequencing, bioinformatics |
|
Physico-chemical characterisation and exposure analysis of nanoparticles in food additives in the context of risk assessment |
EFSA-Nano |
October 1, 2018 |
September 30, 2020 |
Trace elements and nanomaterials, Risk and health impact assessment |
E171, E174, E175, food matrix, image analysis, representative test material, nanoparticles, electron diffraction, energy dispersive X-ray spectroscopy, quantitative electron microscopy, transmission electron microscopy, scanning electron microscopy, high angle annular dark field, scanning transmission electron microscopy, (single particle)-inductively coupled plasma mass spectrometry, risk analysis, exposure assessment, market study |
|
Advanced Computing for European Open Science Cloud (EOSC) |
EGI-ACE |
January 1, 2021 |
June 30, 2023 |
|
research infrastructure, federated services, integrated computing platforms, cross-border data sharing |
|
European health data space pilot for secondary use of health data |
EHDS2 PILOT |
October 1, 2022 |
October 1, 2024 |
Health information |
Research, health data, accessibility, cross-border, European |
|
Monitoring and mitigating environmental health inequalities |
ELLIS |
December 24, 2019 |
December 31, 2023 |
Risk and health impact assessment, Health information |
|
|
Development of experimental models which aim to better understand the biology of emergent HPAI H5Nx viruses and to improve their detection and control |
EMERDIA-H5 II |
January 16, 2019 |
January 15, 2022 |
Avian virology and immunology |
avian influenza virus (AIV), emergent high pathogenic (HP)H5Nx, HPH5 characterisation |
|
Optimisation of virological and serological diagnosis as part of avian influenza monitoring in preparation for the emergence of new highly pathogenic (HP) viruses |
EMERDIAH5 |
January 1, 2017 |
December 31, 2017 |
Avian virology and immunology, Veterinary bacteriology |
avian influenza, differential diagnosis, surveillance, Luminex, ELISA |
|
Preparation of an epidemiological response tool in the event of a sanitary crisis due to a chemical accident |
EMERGENCY PREPAREDNESS |
November 3, 2014 |
|
Risk and health impact assessment |
crises, chemical accident, emergency preparedness, biomonitoring |
|
Screening of possible endocrine disrupting chemicals related to food, evaluation of their oestro/androgenic activity and dietary intake assessment for the Belgian population |
ENDFOODTOX |
May 2, 2019 |
January 1, 2022 |
Organic contaminants and additives, Risk and health impact assessment, Medicines and health products |
endocrine disruptors, food, toxicology, LC-MS, CALUX, food contact materials |
|
NEw opeN Strategy for impUrity suRveillance of commErcial microbial fermentation fooD products: Food supplements and vitamins as proof of concept |
ENSURED |
October 1, 2022 |
September 30, 2025 |
Transversal activities in applied genomics |
impurities of biological origin, genetically modified microorganisms, allergens, microbial fermentation products, food supplements, vitamins, Detection, food safety and traceability, metagenomics, high throughput sequencing, high Resolution Mass Spectometry |
|
Laboratory data networks for surveillance of infectious diseases |
EPI |
January 1, 1983 |
|
Epidemiology of infectious diseases |
surveillance, sentinel laboratory network, National Reference Centres, disease monitoring, infectious diseases, epidemiology, preparedness, outbreak, Be-HERA architecture |
|
Notifiable infectious diseases |
EPI |
January 1, 2007 |
|
Epidemiology of infectious diseases |
|
|
Exposure Risk Assessments |
ERA |
January 1, 2004 |
|
Health information |
food, additives, contaminants, exposure, risk assesment |
|
European regimen accelerator for Tuberculosis |
ERA4TB |
January 1, 2020 |
December 31, 2024 |
Bacterial diseases |
tuberculosis, multidrug-resistant TB, drugs, treatment |
|
European Surveillance of Antimicrobial Consumption Network |
ESAC-Net |
November 30, 2011 |
|
Healthcare-associated infections and antimicrobial resistance |
surveillance, antimicrobial consumption, community, hospital |
|
EU interoperability with HERA’s IT platform |
EU-HIP |
January 1, 2023 |
June 30, 2025 |
Health information, Epidemiology of infectious diseases |
health threat assessment, public health surveillance, medical countermeasures, crossborder data sharing |
|
European Federation for Cancer Images |
EUCAIM |
January 1, 2023 |
January 31, 2027 |
Cancer centre |
cancer, cancer imaging, data infrastructure, artificial intelligence, prediction model |
|
Impact of COVID-19 on the Meuse-Rhine Euroregion |
euPrevent COVID |
August 1, 2020 |
December 31, 2021 |
|
|
|
European programme for the establishment of validated procedures for the detection and identification of biological toxins |
EuroBioTox |
June 1, 2017 |
May 31, 2022 |
Foodborne pathogens, Organic contaminants and additives |
detection identification and authentication, Chemical Biological Radiological and Nuclear (CBRN) protection, biological toxins, standardisation, proficiency testing, certified reference materials, animal replacement methods |
|
European Vaccination Beyond COVID-19 |
EUVABECO |
January 1, 2024 |
June 30, 2026 |
Epidemiology of infectious diseases |
|
